RT Journal Article
SR Electronic
T1 Surveillance of SARS-CoV-2 variants in Argentina: detection of Alpha, Gamma, Lambda, Epsilon and Zeta in locally transmitted and imported cases
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.19.21260779
DO 10.1101/2021.07.19.21260779
A1 Carolina, Torres
A1 Laura, Mojsiejczuk
A1 Dolores, Acuña
A1 Sofía, Alexay
A1 Ariel, Amadio
A1 Paula, Aulicino
A1 Humberto, Debat
A1 Franco, Fernández
A1 Stephanie, Goya
A1 Guido, König
A1 Mercedes, Nabaes Jodar
A1 Luis, Pianciola
A1 Sofía, Bengoa
A1 Marco, Cacciahue
A1 Cecilia, Camussone
A1 José, Dus Santos María
A1 Florencia, Eberhardt María
A1 Ailen, Fernandez
A1 Inés, Gismondi María
A1 Matías, Irazoqui
A1 Silvina, Lusso
A1 Nathalie, Marquez
A1 Marianne, Muñoz
A1 Mónica, Natale
A1 Belén, Pisano
A1 Andrea, Puebla
A1 Viviana, Re
A1 Ezequiel, Sosa
A1 Jonathan, Zaiat
A1 Sebastián, Zunino
A1 Darío, Do porto
A1 Elina, Acevedo María
A1 Cristina, Alvarez Lopez
A1 Laura, Álvarez María
A1 Patricia, Angeleri
A1 Andrés, Angelletti
A1 Manuel, Arca
A1 Gabriela, Barbas
A1 Ana, Bertone
A1 Agustina, Bonnet
A1 Ignacio, Bourlot
A1 Alejandro, Castello
A1 Gonzalo, Castro
A1 Carolina, Ceriani
A1 Carlos, Cimino
A1 Julián, Cipelli
A1 María, Colmeiro
A1 Andrés, Cordero
A1 Carolina, Cristina
A1 Sofia, Di Bella
A1 Regina, Ercole
A1 Yesica, Espasandin
A1 Carlos, Espul
A1 Andrea, Falaschi
A1 Facundo, Fernandez Moll
A1 Andrea, Gatelli
A1 Sandra, Goñi
A1 Estela, Jofré María
A1 José, Jaramillo
A1 Natalia, Labarta
A1 Agustina, Lacaze María
A1 Rocio, Larreche
A1 Viviana, Leiva
A1 Gustavo, Levin
A1 Erica, Luczak
A1 Marcelo, Mandile
A1 Carla, Massone
A1 Melina, Mazzeo
A1 Carla, Medina
A1 Belén, Monaco
A1 Luciana, Montoto
A1 Viviana, Mugna
A1 Alejandra, Musto
A1 Guillermo, Ojeda
A1 Carolina, Pintos
A1 Marcia, Pozzati
A1 Marilina, Rahhal
A1 Claudia, Rechimont
A1 Federico, Remes Lenicov
A1 Gabriela, Rompato
A1 Vanesa, Seery
A1 Leticia, Siri
A1 Julieta, Spina
A1 Cintia, Streitenberger
A1 Ariel, Suárez
A1 Jorgelina, Suárez
A1 Paula, Sujanski
A1 Manuel, Talia Juan
A1 Clara, Theaux
A1 Guillermo, Thomas
A1 Marina, Ticeira
A1 Estefanía, Tittarelli
A1 Rosana, Toro
A1 Osvaldo, Uez
A1 Belén, Zaffanella María
A1 Cecilia, Ziehm
A1 Martin, Zubieta
A1 ,
A1 Alicia, Mistchenko
A1 Laura, Valinotto
A1 Mariana, Viegas
YR 2021
UL http://medrxiv.org/content/early/2021/07/22/2021.07.19.21260779.abstract
AB Molecular surveillance of SARS-CoV-2 variants was performed on a total of 2,406 samples from the capital city and nine provinces of Argentina, during 30 epidemiological weeks (EW) that covered the end of the first wave and the beginning of the ongoing second wave of the COVID-19 pandemic in the country (EW 44/2020 to EW 20/2021). The surveillance strategy was mainly based on Sanger sequencing of a Spike coding region that allows the simultaneous identification of signature mutations associated with worldwide circulating variants. In addition, whole SARS-CoV-2 genome sequences were obtained from 456 samples. The main variants found were Gamma, Lambda and Alpha, and to a lesser extent, Zeta and Epsilon. Whereas Gamma dominated in different regions of the country, both Gamma and Lambda prevailed in the most populated area, the metropolitan region of Buenos Aires (MABA), although showing a heterogeneous distribution along this region. This cost-effective surveillance protocol allowed for a rapid response in a limited access to resources scenario, added information on the expansion of the Lambda variant in South America and contributed to the implementation of public health measures to control the disease spread in Argentina.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Proyecto IP COVID-19 N 08 and Focem COF 03/11 Covid-19.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been appropriately followed. The study was approved by the Ethics Committee of the Hospital de Ninos Ricardo Gutierrez, CABA, Argentina.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe sequences obtained in this study can be found in the online repository GISAID.